← Back to directory

Ingrid Pabinger

Researcher Next ID · RN-030666

Researcher · Medicine

Medical University of Vienna

Vienna, Austria

Not currently recruitingFunding unknown
Works count
1,253
Citation count
33,001
H-index
89
i10-index
420

Research interests

Medicine
Venous Thromboembolism Diagnosis and Management
Blood Coagulation and Thrombosis Mechanisms
Platelet Disorders and Treatments
Hemophilia Treatment and Research
Atrial Fibrillation Management and Outcomes

Publications

  • 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology · 2022 · 10.1016/s1470-2045(22)00160-7

  • Cancer-associated venous thromboembolism

    Nature Reviews Disease Primers · 2022 · 10.1038/s41572-022-00336-y

  • Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis

    Research and Practice in Thrombosis and Haemostasis · 2020 · 10.1002/rth2.12439

  • 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30336-5

  • Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

    Journal of Thrombosis and Haemostasis · 2018 · 10.1111/jth.13951

  • A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

    The Lancet Haematology · 2018 · 10.1016/s2352-3026(18)30063-2

  • International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

    The Lancet Oncology · 2016 · 10.1016/s1470-2045(16)30369-2

  • Cancer-associated venous thromboembolism: Burden, mechanisms, and management

    Thrombosis and Haemostasis · 2016 · 10.1160/th16-08-0615

  • Biomarkers for prediction of venous thromboembolism in cancer

    Blood · 2013 · 10.1182/blood-2013-04-460147

  • Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

    Blood · 2013 · 10.1182/blood-2013-10-529974

  • International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Journal of Thrombosis and Haemostasis · 2012 · https://doi.org/10.1111/jth.12070

  • International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

    Journal of Thrombosis and Haemostasis · 2012 · 10.1111/jth.12071

  • Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

    Journal of Thrombosis and Haemostasis · 2012 · 10.1111/j.1538-7836.2012.04754.x

  • High D-dimer levels are associated with poor prognosis in cancer patients

    Haematologica · 2012 · 10.3324/haematol.2011.054718

  • Prediction of venous thromboembolism in cancer patients

    Blood · 2010 · https://doi.org/10.1182/blood-2010-02-270116

  • Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

    New England Journal of Medicine · 2010 · 10.1056/nejmoa1002625

  • D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.21.7752

  • A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

    Nature Genetics · 2009 · 10.1038/ng.341

  • The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

    Journal of Thrombosis and Haemostasis · 2009 · 10.1111/j.1538-7836.2009.03588.x

  • High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

    Journal of Thrombosis and Haemostasis · 2009 · 10.1111/j.1538-7836.2009.03680.x

  • Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy

    CHEST Journal · 2008 · https://doi.org/10.1378/chest.08-0761

  • High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

    Blood · 2008 · 10.1182/blood-2008-02-142422

  • Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

    Journal of Thrombosis and Haemostasis · 2008 · 10.1111/j.1538-7836.2008.02904.x

  • Wilson's disease in patients presenting with liver disease: A diagnostic challenge

    Gastroenterology · 1997 · 10.1016/s0016-5085(97)70097-0

  • Increased fetal loss in women with heritable thrombophilia

    The Lancet · 1996 · https://doi.org/10.1016/s0140-6736(96)04125-6

Current projects

    No projects listed.